A retrospective study assessing the impact of BMI on the short-term and long-term efficacy of biological therapies in clinical practice and to identify the best therapeutic options in obese patients
Latest Information Update: 22 Sep 2021
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Ixekizumab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- 22 Sep 2021 New trial record
- 18 Sep 2021 Results published in the Clinical Drug Investigation